3型原发性高氧化尿症的中国儿童的不同临床特征
Zhenqiang Zhao1,2, Jingtao Zhi1,2, Yucheng Ge1,2
1Department of Urology, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China.
Pediatric nephrology (Berlin, Germany)
|November 14, 2025
概括
儿童的初级3型高氧化尿症 (PH3) 呈现为早期发病,瘤瘤和明显的尿路变化. 识别这些特征有助于更早地诊断PH3,这是一种罕见的遗传疾病.
科学领域:
- 儿科脏病学 儿科脏病学
- 医学遗传学 医学遗传学
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
背景情况:
- 主要3型高氧化尿症 (PH3) 是一种罕见的自体相衰退性疾病,具有诊断挑战.
- 区分PH3与非PH患者的独特临床特征可以帮助诊断.
研究的目的:
- 为了比较儿科患者与PH3和非PH患者的临床特征.
- 确定促进早期诊断PH3.3的关键特征.
主要方法:
- 对患有尿病的儿科患者的临床数据进行分析,这些患者接受了全外组测序.
- 根据基因检测结果将患者分为PH3和非PH组.
主要成果:
- 与非PH患者相比,PH3患者的发病时间较早 (0.9 vs 2.0年) 和骨瘤发病率较高 (22.22% vs 3.17%).
- PH3患者的尿氧酸和酸盐水平显著提高 (333.70比170.84微克/毫克),尿水平降低 (113.27比352.21微克/毫克).
- 亚组分析证实PH3患者的尿氧酸盐升高和尿降低,与其他与石头相关的遗传组和具有负分子诊断的基因组相比.
结论:
- 儿科PH3的特点是早期发病,瘤,尿氧酸的增加和尿的减少.
- 这些发现为儿童群体早期诊断PH3提供了有价值的指导.
相关概念视频
Chronic Kidney Disease II: Clinical Manifestations
537
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
537
Pharmacokinetics in Pediatric Patients: Drug Metabolism
182
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
182
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
234
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
234
Inborn Errors of Metabolism
688
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
688
Acute Kidney Injury III: Clinical Manifestations
791
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
791
Pleiotropy
43.1K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
43.1K


